Cardiovascular drugs in the perioperative period:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York
Author's Publ. House [u.a.]
1999
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XII, 391 S. Ill., graph. Darst. |
ISBN: | 0620230991 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV012511239 | ||
003 | DE-604 | ||
005 | 19990610 | ||
007 | t | ||
008 | 990415s1999 ad|| |||| 00||| eng d | ||
020 | |a 0620230991 |9 0-620-23099-1 | ||
035 | |a (OCoLC)41515831 | ||
035 | |a (DE-599)BVBBV012511239 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
050 | 0 | |a RM345 | |
084 | |a XI 4323 |0 (DE-625)153005:12929 |2 rvk | ||
245 | 1 | 0 | |a Cardiovascular drugs in the perioperative period |c eds. Pierre Foëx ... |
264 | 1 | |a New York |b Author's Publ. House [u.a.] |c 1999 | |
300 | |a XII, 391 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Cardiovascular Agents |x pharmacology | |
650 | 4 | |a Cardiovascular Agents |x therapeutic use | |
650 | 4 | |a Cardiovascular Diseases |x drug therapy | |
650 | 4 | |a Cardiovascular agents |x Therapeutic use | |
650 | 4 | |a Cardiovascular pharmacology | |
650 | 4 | |a Heart |x Diseases |x Chemotherapy | |
650 | 4 | |a Perioperative Care | |
650 | 4 | |a Surgery | |
650 | 0 | 7 | |a Perioperative Phase |0 (DE-588)4173783-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Kreislaufmittel |0 (DE-588)4163325-8 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Kreislaufmittel |0 (DE-588)4163325-8 |D s |
689 | 0 | 1 | |a Perioperative Phase |0 (DE-588)4173783-0 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Foëx, Pierre |e Sonstige |4 oth | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008491775&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-008491775 |
Datensatz im Suchindex
_version_ | 1804127154203525120 |
---|---|
adam_text | CONTENTS
Page
Contributing authors iii
Foreword v
Preface vii
A. PHARMACOLOGY OF CARDIOVASCULAR
DRUGS IN PERIOPERATIVE USE
Chapter
1. Autonomic receptors and signal systems as sites of
action of cardiovascular drugs
Lionel H Opie
Autonomic nervous system 1
Receptors and signals in contractile myocardium 6
Sinus node pacemaker activity 9
Vascular control 11
Vasodilatory local messengers 12
Pharmacological vasodilation 15
Endothelial dysfunction 16
Baroreflexes and control of blood pressure 17
Control of cell calcium 18
Ion channels and drug action 20
Ventricular action potential 25
Restitution of myocardial ionic balance 27
Summary 28
2. Effects of anesthetic agents on heart and circulation
Hans Joachim Priebe
Anesthetics and the autonomic nervous system 35
Techniques used to assess cardiovascular
performance 37
Volatile anesthetics and cardiovascular
performance 40
Intravenous anesthetics and cardiovascular
performance 47
Anesthetics and blood volume distribution 50
Summary 50
3. Adrenergic receptor agonists in anesthetic practice
Michael G Mythen, Debra A Schwinn
Pharmacodynamics and mechanisms of action of
adrenergic receptor agonists 60
Endogenous catecholamines 62
Synthetic catecholamines 68
Sympathomimetic amines 73
Phosphodiesterase inhibitors 76
Summary 79
4. Adrenergic inhibitors
Joseph D Meyer, Jr., Noel W Lawson
Peripheral adrenergic receptor antagonists 83
Beta adrenoceptor antagonists 85
Alpha adrenoceptor antagonists 94
Dopaminergic adrenoceptor antagonists 100
Autonomic ganglion antagonists 101
Drugs which form false sympathetic
neurotransmitters 102
Drugs which deplete stores of sympathetic
neurotransmitters 104
Drugs which inhibit presynaptic release of
sympathetic neurotransmitter 105
Summary 106
Calcium channel antagonists and other agents
decreasing calcium influx
Lionel H Opie, Gaisford G Harrison
Calcium channel antagonists in anesthetic practice 111
Mechanisms of action and pharmacodynamics of
CCAs 111
CCAs and pre anesthetic assessment 116
CCAs: Dosage schedules and pharmacokinetics 119
Perianesthetic use 119
Interactions of CCAs and anesthetics 125
Management of adverse interactions 127
CCAs and organ protection 128
Magnesium: a CCA like agent 129
Summary 132
Vascular smooth muscle and vasodilators
Bruce } Leone
Nitric oxide donors 141
Renin angiotensin system 147
ACE inhibitors 149
Angiotensin II receptor antagonists 151
Adenosine 152
Summary 155
DRUG MANAGEMENT OF DISEASE AND
DISASTER IN THE PERIOPERATIVE PERIOD
Arrhythmias and their management in the
perioperarive period
John L Atlee, Gaisford G Harrison
Arrhythmias and ion channels: mechanisms of
arrhythmogenesis 161
Cardiac electrophysiology 162
Impulse generation 166
Impulse propagation 168
Cellular mechanisms for arrhythmias 169
Specific management. Antiarrhythmic drugs 177
Perioperative arrhythmogenic environment 200
Defibrillation, cardioversion and pacing 205
Summary 207
8. Hypertension in the perioperative period and its
management
Pierre Foe x, Simon ] Howell, Lionel H Opie
Pathophysiology of hypertension 215
Long term treatment of arterial hypertension 220
Special patient groups 228
Preoperative evaluation of hypertension 231
Perioperative risks and their management 233
Conclusions 239
Summary 240
9. Coronary artery disease and myocardial ischemia
Pierre Foe x
Pathophysiology of coronary disease 248
Treatment of coronary artery disease 251
Treatment of specific clinical syndromes 257
Coronary risk factors in surgical patients 259
Preoperative tests for myocardial ischemia 262
Management of perioperative ischemia 263
Maintenance of beta blockade in the
perioperative period 265
Maintenance of circulation and myocardial
schema 265
Effects of anesthetic agents on the compromised
heart 267
Conclusions: Anesthetic agents and the
compromised heart 270
Summary 270
10. Heart failure and its therapy in the perioperative
period
Gaisford G Harrison, Lionel H Opie
Pathophysiology of congestive heart failure 278
Principles of drug treatment of CHF 280
Natriuresis and reduction in preload by diuretics 281
Inhibition of neurohumoral response 284
Inhibition of the renin angiotensin system (RAS) 284
Reduction in pre and afterload by vasodilators 290
CHF with predominant diastolic dysfunction 296
Enhancement of myocardial contractility with
inotropes 296
Acute or intractable heart failure 304
Novel therapies 304
Management policy for patients in CHF requiring
surgery 304
Summary 305
11. Cardiopulmonary resuscitation and critical care
management
Thomas J Monaco, Jr., ]ames Ramsay
Cardiopulmonary arrest 314
Resuscitation physiology 315
Principles of resuscitation 317
Ventricular fibrillation/pulseless ventricular
tachycardia 321
Pulseless electrical activity 323
Controversies in resuscitation pharmacology 324
ICU management 332
Acute myocardial infarction 334
Cardiac arrhythmias 336
Summary 343
12. Vasoactive drugs and cardiopulmonary bypass
Lisa Wollman, Daniel M Philbin
Rationale of inotropic administration 350
Inotropic agents 351
Vasodilators 359
Venodilators 362
Vasoconstrictors 363
Summary 364
INDEX 367
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV012511239 |
callnumber-first | R - Medicine |
callnumber-label | RM345 |
callnumber-raw | RM345 |
callnumber-search | RM345 |
callnumber-sort | RM 3345 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 4323 |
ctrlnum | (OCoLC)41515831 (DE-599)BVBBV012511239 |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01762nam a2200457 c 4500</leader><controlfield tag="001">BV012511239</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990610 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">990415s1999 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0620230991</subfield><subfield code="9">0-620-23099-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)41515831</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV012511239</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM345</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 4323</subfield><subfield code="0">(DE-625)153005:12929</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular drugs in the perioperative period</subfield><subfield code="c">eds. Pierre Foëx ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Author's Publ. House [u.a.]</subfield><subfield code="c">1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 391 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular agents</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cardiovascular pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Heart</subfield><subfield code="x">Diseases</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Perioperative Care</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Surgery</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Perioperative Phase</subfield><subfield code="0">(DE-588)4173783-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Kreislaufmittel</subfield><subfield code="0">(DE-588)4163325-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Perioperative Phase</subfield><subfield code="0">(DE-588)4173783-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Foëx, Pierre</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008491775&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008491775</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV012511239 |
illustrated | Illustrated |
indexdate | 2024-07-09T18:28:50Z |
institution | BVB |
isbn | 0620230991 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008491775 |
oclc_num | 41515831 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | XII, 391 S. Ill., graph. Darst. |
publishDate | 1999 |
publishDateSearch | 1999 |
publishDateSort | 1999 |
publisher | Author's Publ. House [u.a.] |
record_format | marc |
spelling | Cardiovascular drugs in the perioperative period eds. Pierre Foëx ... New York Author's Publ. House [u.a.] 1999 XII, 391 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular agents Therapeutic use Cardiovascular pharmacology Heart Diseases Chemotherapy Perioperative Care Surgery Perioperative Phase (DE-588)4173783-0 gnd rswk-swf Kreislaufmittel (DE-588)4163325-8 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Kreislaufmittel (DE-588)4163325-8 s Perioperative Phase (DE-588)4173783-0 s DE-604 Foëx, Pierre Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008491775&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Cardiovascular drugs in the perioperative period Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular agents Therapeutic use Cardiovascular pharmacology Heart Diseases Chemotherapy Perioperative Care Surgery Perioperative Phase (DE-588)4173783-0 gnd Kreislaufmittel (DE-588)4163325-8 gnd |
subject_GND | (DE-588)4173783-0 (DE-588)4163325-8 (DE-588)4143413-4 |
title | Cardiovascular drugs in the perioperative period |
title_auth | Cardiovascular drugs in the perioperative period |
title_exact_search | Cardiovascular drugs in the perioperative period |
title_full | Cardiovascular drugs in the perioperative period eds. Pierre Foëx ... |
title_fullStr | Cardiovascular drugs in the perioperative period eds. Pierre Foëx ... |
title_full_unstemmed | Cardiovascular drugs in the perioperative period eds. Pierre Foëx ... |
title_short | Cardiovascular drugs in the perioperative period |
title_sort | cardiovascular drugs in the perioperative period |
topic | Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular agents Therapeutic use Cardiovascular pharmacology Heart Diseases Chemotherapy Perioperative Care Surgery Perioperative Phase (DE-588)4173783-0 gnd Kreislaufmittel (DE-588)4163325-8 gnd |
topic_facet | Cardiovascular Agents pharmacology Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Cardiovascular agents Therapeutic use Cardiovascular pharmacology Heart Diseases Chemotherapy Perioperative Care Surgery Perioperative Phase Kreislaufmittel Aufsatzsammlung |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=008491775&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT foexpierre cardiovasculardrugsintheperioperativeperiod |